全部| 求助中| 待确认 按时间排序|按积分排序

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study

用户EO9nReo4Hj6s 6天前 10 已完结

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer

用户EO9nReo4Hj6s 6天前 10 已完结

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis

用户CdkKEKgsl6A8 6天前 10 已完结

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial

用户EO9nReo4Hj6s 6天前 10 已完结

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer

用户EO9nReo4Hj6s 6天前 10 已完结

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial

用户EO9nReo4Hj6s 6天前 10 已完结

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer

用户EO9nReo4Hj6s 6天前 10 已完结

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction …

用户anbt0_mWgNQY 6天前 10 已完结

Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis

用户anbt0_mWgNQY 6天前 10 已完结

Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis

用户jVLEDgPjrAis 6天前 10 已完结
首页 上页 32 33 34 35 36 37 38 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com